Increased Generation of Superoxide by Angiotensin II in Smooth Muscle Cells from Resistance Arteries of Hypertensive Patients: Role of Phospholipase D-dependent NAD(P)H Oxidase-sensitive Pathways
Overview
Authors
Affiliations
Objective: We tested the hypothesis that increased responsiveness of phospholipase D (PLD) to angiotensin II (Ang II) is associated with increased oxidative stress and exaggerated growth responses in vascular smooth muscle cells (VSMC) from untreated essential hypertensive patients.
Design: VSMCs from peripheral resistance arteries of normotensive and hypertensive subjects were studied. Production of reactive oxygen species (ROS) was measured with the fluoroprobe 5-(and 6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA). PLD and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) oxidase were assessed with the inhibitors, dihydro-D-erythro-sphingosine (sphinganine) and diphenylene iodinium (DPI), respectively, and protein kinase C (PKC) effects were determined using chelerythrine chloride and calphostin C. PLD activity was measured by the transphosphatidylation assay.
Results: Ang II increased the CM-H2DCFDA fluorescence signal, derived predominantly from H2O2. Ang II-induced generation of DPI-inhibitable ROS was significantly enhanced in cells from hypertensives compared with normotensives (Emax = 72 +/- 2 versus 56.9 +/- 1.8 fluorescence units, P< 0.01). PLD inhibition attenuated Ang II-induced ROS generation, with greater effects in the hypertensive group than the normotensive group (delta = 42 +/- 3.3 versus 21 +/- 2 units). PKC inhibition partially decreased Ang II-elicited signals. Ang II-stimulated PLD activity and DNA and protein synthesis were significantly greater in cells from hypertensives than normotensives. These effects were normalized by DPI and sphinganine.
Conclusions: Our results suggest that in essential hypertension enhanced oxidative stress and augmented growth-promoting actions of Ang II are associated with increased activation of PLD-dependent pathways. These processes may contribute to vascular remodeling in hypertension.
Microvascular endothelial dysfunction in vascular senescence and disease.
Kasal D, Sena V, Huguenin G, De Lorenzo A, Tibirica E Front Cardiovasc Med. 2025; 12:1505516.
PMID: 40041173 PMC: 11878104. DOI: 10.3389/fcvm.2025.1505516.
Luan M, Tian Y, Yan D, Liang S Front Endocrinol (Lausanne). 2024; 15:1373095.
PMID: 38711984 PMC: 11070464. DOI: 10.3389/fendo.2024.1373095.
Frara N, Giaddui D, Braverman A, Jawawdeh K, Wu C, Ruggieri Sr M PLoS One. 2023; 18(6):e0287212.
PMID: 37352265 PMC: 10289437. DOI: 10.1371/journal.pone.0287212.
Prasad K Int J Angiol. 2023; 31(4):213-221.
PMID: 36588874 PMC: 9803554. DOI: 10.1055/s-0042-1756175.
Yang Y, Nourian Z, Li M, Sun Z, Zhang L, Davis M Front Physiol. 2022; 13:871968.
PMID: 35832482 PMC: 9272009. DOI: 10.3389/fphys.2022.871968.